Fortress Biotech Inc.
FBIO | NASDAQ
$2.42
+$0.01 (+0.41%)
Sep 22, 2026, 9:44 AM ET · Market open
Market Data
Market Cap $80.06M
Enterprise Value $-63.2M
Beta 1.19
Average Volume 533.75K
Shares Outstanding (Diluted) 31.79M
Shares Change YoY 6.6%
Institutional Ownership 16.99%
Exchange NASDAQ
ISIN US34960Q3074
Price Performance
Price Change 1M -14.8%
Price Change 3M -23.7%
Price Change 6M -19.4%
Price Change YTD -40.2%
Price Change 1Y -39.8%
Price Change 3Y -46.4%
Price Change 5Y -95.5%
1M CAGR (ann.) -9.7%
1Y CAGR (ann.) -32.3%
5Y CAGR (ann.) -45.4%
All-Time CAGR -24.8%
Valuation
PE Ratio 0.91
Forward PE 0.52
PEG Ratio 0.00
Forward PEG -0.01
PS Ratio 1.18
Forward PS 0.70
PB Ratio 0.49
P/FCF Ratio 0.43
P/Adj. FCF Ratio 0.45
P/OCF Ratio 0.61
EV/Sales -0.94
EV/EBIT -0.41
EV/EBITDA -0.43
EV/FCF -0.34
Earnings Yield 110.0%
FCF Yield 231.3%
Adj. FCF Yield 224.3%
Financial Health
Net Cash $143.26M
Total Debt $53.32M
Cash & Short-Term Investments $196.58M
Total Assets $316.72M
Current Ratio 3.96
Quick Ratio 3.83
Debt / Equity Ratio 0.39
Debt / EBITDA 0.36
Debt / FCF 0.29
OCF / Debt 3.47
Interest Coverage -3.27
Altman Z-Score 0.17
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 62.5%
Operating Profit Margin -43.4%
EBITDA Margin 233.4%
Net Profit Margin 163.3%
FCF Margin 274.0%
Adj. FCF Margin 265.6%
SBC / Revenue 8.3%
SBC Impact (per share) -3.0%
Returns
Return on Assets 35.3%
Return on Equity 103.5%
Return on Invested Capital -10.8%
Return on Capital Employed -11.5%
Return on Tangible Assets 38.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 2.5%
Revenue CAGR 5Y 5.1%
Revenue CAGR 10Y 35.4%
EPS CAGR 3Y 408.8%
EPS CAGR 5Y 73.8%
EPS CAGR 10Y 32.7%
FCF CAGR 3Y 8380.0%
FCF CAGR 5Y 115.2%
FCF CAGR 10Y 15.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 6
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 15, 2026
EPS Estimate (next Q) -$0.27
EPS Growth Est (next Q) -345.4%
Revenue Est (next Q) $21.58M
Revenue Growth Est (next Q) 22.4%
Fair Value Estimates
Graham Number $19.70
Graham Upside 717.4%
Lynch Fair Value $66.25
Lynch Upside 2649.0%
Price Target $5
Price Target Upside 107.5%
Cash Flow
Operating Cash Flow $185.2M
Free Cash Flow $185.2M
Adj. Free Cash Flow $179.54M
FCF Per Share $3.97
OCF Per Share $3.98
OCF/S Ratio 183.9%
Income Statement
Revenue $67.59M
Gross Profit $31.21M
Operating Income $-29.35M
EBITDA $146.43M
Net Income $109.81M
EPS (Diluted) $2.65
Revenue / Employee $866.5K
Profit / Employee $1.41M
Employees 78
Add to Watchlist
Select watchlists to add or remove FBIO